JNK (c-Jun N-terminal kinase), a kinase subfamily belonging to the MAPK, is activated in response to various stress stimuli and possesses a wide variety of regulatory functions.Three isoforms of the serine/threonine protein kinase JNK family (JNK1, JNK2, and JNK3) exist. JNKs play a role in the development and progression of many pathologies, including cancer, inflammatory diseases, cardiovascular and metabolic disorders, and neurodegenerative diseases.
JNKs are triggered by a phosphorylation cascade that typically involves two different upstream kinases, the so-called MAP kinase kinase kinases (MAP3K, MKKK) and the MAP kinase kinases (MAP2K; MKK). This process is similar to that used to activate the other MAP kinases. JNKs are triggered by MKK4 and MKK7 at the MAP2K level; the former is a shared activator of the JNK and p38 MAP kinase signaling pathways. The JNK cascade is a component of a complicated signaling network since it crosses numerous other routes at different places.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V96640 | JNK-1-IN-4 | 3047795-60-5 | JNK-1-IN-4 (Compound E1) is a JNK inhibitor that inhibits JNK-1, JNK-2, and JNK-3 with IC50 of 2.7, 19.0, and 9.0 nM, respectively. |
![]() |
V80459 | JNK-IN-12 | JNK-IN-12 (compound P2) is a mitochondria-targeted JNK inhibitor (IC50=66.3 nM), consisting of a mitochondria-specific cell-penetrable peptide and JNK-specific inhibitor SP600125. | |
![]() |
V74393 | JNK-IN-13 | 345986-38-1 | JNK-IN-13 (compound 1) is a potent and specific JNK inhibitor (antagonist) with IC50s of 290 nM and 500 nM for JNK3 and JNK2, respectively. |
![]() |
V85692 | JNK-IN-15, Cell-Permeable | ||
![]() |
V85683 | JNK-IN-15, Cell-Permeable, Negative Control | ||
![]() |
V94893 | JNK-IN-18 | JNK-IN-18 (compound 23b) is a JNK1 inhibitor with IC50 of 2 nM, while JNK2 and BRAF (V600E) have IC50s of 125 nM and 98 nM, respectively. | |
![]() |
V104592 | JNK-IN-19 | 3059122-56-1 | JNK-IN-19 (Compound Q8) is a c-Jun N-terminal kinase inhibitor used to treat and/or prevent pre-operative, intra-operative or post-operative injury. |
![]() |
V104746 | JNK-IN-20 | 346663-56-7 | JNK-IN-20 (Compound 5) is a JNK inhibitor. |
![]() |
V104754 | JNK-IN-21 | 756849-36-2 | JNK-IN-21 (Compound 62) is a JNK-1 inhibitor. |
![]() |
V104735 | JNK-IN-22 | 771503-50-5 | JNK-IN-22 (Compound 58) is a JNK-1 inhibitor. |
![]() |
V12253 | JNK-IN-7 | 1408064-71-0 | JNK-IN-7 is a potent JNK inhibitor, inhibiting JNK1, JNK2 and JNK3 with IC50 of 1.5, 2 and 0.7 nM respectively. |
![]() |
V78318 | JNK2-IN-1 | 2998941-15-2 | JNK2-IN-1 (Compound J27) is a JNK2 inhibitor (Kds: 79.2 Μm). |
![]() |
V74392 | JNK3 inhibitor-3 | 2873465-25-7 | JNK3 inhibitor-3 (compound 15g) is a selective, BBB (blood-brain barrier) penetrating, orally bioactive c-Jun N-terminal kinase 3 (JNK3) inhibitor. |
![]() |
V80457 | JNK3 inhibitor-6 | JNK3 inhibitor-6 (Compound A53) is a selective JNK3 inhibitor (IC50=78 nM). | |
![]() |
V80458 | JNK3 inhibitor-8 | JNK3 inhibitor-8 is a specific, orally bioactive JNK3 inhibitor that can cross the BBB (blood-brain barrier). | |
![]() |
V0473 | TCS JNK 5a | 312917-14-9 | TCS JNK 5a (alsoknown asJNK Inhibitor IX; TCS JNK-5a) is a novel, highly selective and potent JNK (c-Jun N-terminal Kinase) inhibitor with potential antineoplastic activity. |
![]() |
V0472 | JNK-IN-8 | 1410880-22-6 | JNK-IN-8 (JNK Inhibitor XVI; JNK-IN8) is the first irreversible/covalent inhibitor of pan-JNK (c-Jun N-terminal Kinase) with potential antitumor activity. |
![]() |
V28892 | JNK Inhibitor VIII (TCS JNK 6o) | 894804-07-0 | JNK Inhibitor VIII (TCS JNK 6o) isa selective and ATP-competitive inhibitor of c-Jun N-terminal kinases (JNK-1, -2, and -3) with Kis of 2 nM, 4 nM, 52 nM, respectively, and has IC50 of 45 nM and 160 nM for JNK-1 and -2, respectively. |
![]() |
V9844 | KB-R7943 mesylate | 182004-65-5 | KB-R7943 mesylate, the mesylate salt of KB-R-7943, is a novel and potent reverse Na(+) /Ca(2+) exchanger (NCX(rev)) with neuroprotective action. |
![]() |
V51552 | L-JNKI-1 | L-JNKI-1 is a cell-penetrable peptide inhibitor of JNK. |